Preventing peritoneal dialysis related infections

Minerva Urologica e Nefrologica

Volumn 58, Issue 2, 2006, Pages 161-169

  Piraino, B ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Infections; Peritoneal dialysis; Peritonitis; Staphylococcus aureus

Indexed keywords

GENTAMICIN; PSEUDOMONIC ACID; RIFAMPICIN;

FUNGUS GROWTH; HOSPITAL INFECTION; HUMAN; LIVER TOXICITY; MORTALITY; PERITONEAL DIALYSIS; PERITONITIS; RECURRENT INFECTION; REVIEW; RISK FACTOR;

HUMANS; PERITONEAL DIALYSIS; PERITONITIS; RISK FACTORS;

EID: 33745488366     PISSN: 03932249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. U.S. Renal Data System, USRDS 2004 Annual Data Report: Atlas of End Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health National Institute of Diabetes and Digestive and Kidney Disease; 2004.
2. U.S. Renal Data System, USRDS 2005 Annual Data Report: Atlas of End Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health National Institute of Diabetes and Digestive and Kidney Disease; 2005.
3. Fried L, Bernardini J, Johnston JR, Piraino B. Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol 1996;7:2176-82.
4. Chung SH, Heimburer O, Lindholm B, Lee HB. Peritoneal dialysis patient survival: a comparison between a Swedish and a Korean centre. Nephrol Dial Transplant 2005;20:1207-13.
5. Kim GC, Vonesh EF, Korbet SM. The effect of technique failure on outcome in black patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 2002;22:53-9.
6. Schaubel DE, Blake PG, Fenton SSA. Trends in CAPD technique failure: Canada, 1981-1997. Perit Dial Int 2001;21:365-71.
7. CANADA-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996;7:198-207.
8. Schaefer F, Kandert M, Feneberg R. Methodological issues in assessing the incidence of peritoneal dialysis associated peritonitis in children. Perit Dial Int 2002;22:234-8.
9. Gulati S, Stephens D, Balfe JA, Seeker D, Harvey E, Balfe JW. Children with hypoalbuminemia on continuous peritoneal dialysis are at risk for technique failure. Kidney Int 2001;59:236l-7.
10. Mastrosimone S, Virga G, Stanic L, Gastaldon F, da Porto A, Bonadonna A. Low peritonitis rate leads to high patient survival and technique success: the first five years of a peritoneal dialysis program. Perit Dial Int 2002;22:91-3.
11. Wang Q, Bernardini J, Piraino B, Fried L. Albumin at the start of peritoneal dialysis predicts the development of peritonitis. Am J Kidney Dis 2003;41:664-9.
12. Allon M, Radeva M, Bailey J, Beddhu S, Butterly D, Coyne DW et al for the HEMO Study Group. The spectrum of infection-related morbidity in hospitalized haemodialysis patients. Nephrol Dial Transplant 2005;20:1180-6.
13. Aslam N, Bernardini J, Fried L, Burr RA, Piraino B. Comparison of infectious complications betweeen incident hemodialysis and peritoneal dialysis patients: differences by race and diabetes. J Am Soc Nephrol 2005;16:296A.
14. Chow KM, Szeto CC, Leung CB, Law MC, Li PKT. Impact of social factors on patients on peritoneal dialysis. Nephrol Dial Transplant 2005;20:2504-10.
15. Troidle L, Watnick S, Wuerth D, Gorban-Brennan N, Kliger AS, Finkelstein FO. Depression and its association with peritonitis in long-term peritoneal dialysis patients. Am J Kidney Dis 2003;42:350-4.
16. Prowant BF. Nursing interventions related to peritonitis. Adv Ren Replace Ther 1996;3:237-9.
17. Hall G, Bogan A, Dreis S, Duffy A, Green S, Kelley K et al. New directions in peritoneal dialysis patient training. Nephrol Nurs J 2004;31:149-63.
18. Miller TE, Findon G. Touch contamination of connection devices in peritoneal dialysis - a quantitative microbiologic analysis. Perit Dial Int 1997;17:560-7.
19. Borg D, Shetty A, Williams D, Faber MD. Fivefold reduction in peritonitis using a multifaceted continuous quality initiative program. Adv Perit Dial 2003;19:202-5.
20. Canadian CAPD Clinical Trials Group. Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a multi-centre randomized clinical trial comparing the Y connector disinfectant system to standard systems. Perit Dial Int 1989;9:159-63.
21. Harris DCH, Yuill EJ, Byth K, Chapman JR, Hunt C. Twin versus single bag disconnect systems: infection rates and cost of continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1996;7:2392-8.
22. Li PKT, Law MC, Chow KM, Chan WK, Szeto CC, Cheng YL et al. Comparison of clinical outcome and ease of handling in two double-bag systems in continuous ambulatory peritoneal dialysis - A prospective randomized controlled multi-center study. Am J Kidney Dis 2002;40:373-80.
23. Monteon F, Correa-Rotter R, Paniagua R, Amato D, Hurtado ME, Medina JL et al. Prevention of peritonitis with disconnect systems in CAPD: a randomized controlled trial. Kidney Int 1998;54:2123-8.
24. Kim DK, Yoo TH, Ryu DR, Xu ZG, Kim HJ, Choi KH et al. Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center's experience over one decade. Perit Dial Int 2004;24:424-32.
25. Zelenitsky S, Barns L, Findlay I, Alfa M, Ariano R, Fine A et al. Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis 2000;36:1009-13.
26. Piraino B, Bernardini J, Fried L. S. aureus prophylaxis and trends in Gram negative infections in peritoneal dialysis patients. Perit Dial Int 2003;23:456-9.
27. Ponferrada LP, Prowant BF, Rackers JA, Pickett B, Satalowich R, Khanna R et al. A cluster of Gram-negative peritonitis episodes associated with reuse of HomeChoice cycler cassettes and drain lines. Perit Dial Int 1996;16:636-8.
28. Chow J, Munro C, Wong M, Gonzalez N, Ku M, Neville S et al. HomeChoice automated peritoneal dialysis machines: the impact of reuse of tubing and cassettes. Perit Dial Int 2000;20:336-48.
29. Piraino B, Bernardini J, Sorkin M. The influence of peritoneal catheter exit-site infections on peritonitis, tunnel infections, and catheter loss in patients on CAPD. Am J Kidney Dis 1986;8:436-40.
30. Abraham G, Savin E, Ayiomamitis, Sharron I, Vas SI, Mathews RE et al. Natural history of exit-site infection (ESI) in patients on continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Bull 1988;8:211-6.
31. Plum J, Sudkamp S, Grabensee B. Results of ultra-sound-assisted diagnosis of tunnel infections in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1994;23:99-104.
32. Vychytil A, Lorenz M, Schneider B, Horl WH, Haag-Weber M. New strategies to prevent Stapbylococcus aureus infections in peritoneal dialysis patients. J Am Soc Nephrol 1998;9:669-76.
33. Vychytil A, Lorenz M, Schneider B, Horl WH, Haag-Weber M. New criteria for management of catheter infections in peritoneal dialysis patients using ultrasonography. J Am Soc Nephrol 1998;9:290-6.
34. Gupta B, Bernardini J, Piraino B. Peritonitis associated with exit site and tunnel infections. Am J Kidney Dis 1996;28:415-9.
35. Bernardini J, Piraino B, Sorkin M. Analysis of continuous ambulatory peritoneal dialysis-related Pseudomonas aeruginosa infections. Am J Med 1987;83:829-32.
36. Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C et al.; ISPD Ad Hoc Advisory Committee. Peritoneal dialysis related infection recommendations: 2005 update. Perit Dial Int 2005;25:107-31.
37. Danielsson A, Blohme L, Tranaeus A, Hylander B. A prospective randomized study of the effect of a subcutaneously 'buried' peritoneal dialysis catheter technique versus standard technique on the incidence of peritonitis and exit-site infection. Perit Dial Int 2002;22:211-9.
38. Eklund BH, Honkanen EO, Kala AR, Kyllonen LE. Catheter configuration and outcome in patients on continuous ambulatory peritoneal dialysis: a prospective comparison of two catheters. Perit Dial Int 1994;14:70-4.
39. Eklund BH, Honkanen EO, Kala AR, Kyllonen LE. Peritoneal dialysis access: prospective randomized comparison of the Swan Neck and Tenckhoff catheters. Perit Dial Int 1995;15:353-6.
40. Eklund B, Honkanen E, Kyllonen L, Salmela K, Kala AR. Peritoneal dialysis access: prospective randomized comparison of single-cuff and double-cuff straight Tenckhoff catheters. Nephrol Dial Transplant 1997;12:2664-6.
41. Strippoli GFM, Tong A, Johnson D, Schena FP, Craig JC. Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials. J Am Soc Nephrol 2004;15:2735-46.
42. Bennett-Jones DN, Martin J, Barratt AJ, Duffy TJ, Naish PF, Aber GM. Prophylactic gentamicin in the prevention of early exit-site infections and peritonitis in CAPD. Adv Perit Dial 1988;4:147-50.
43. Lye WC, Lee EJ, Tan CC. Prophylactic antibiotics in the insertion of Tenckhof catheters. Scand J Urol Nephrol 1992;26:177-80.
44. Gadallah M, Ramdeen G, Mignone J, Patel D, Mitchell L, Tatro S. Role of preoperative antibiotic prophylaxis in preventing postoperative peritonitis in newly placed peritoneal dialysis catheters. Am J Kidney Dis 2000;36:1014-9.
45. Lye WC, Leong SO, van der Straaten J, Lee E. Stapbylococcus aureus CAPD related infections are associated with nasal carriage. Adv Perit Dial 1994;10:163-5.
46. Lye WC, Leong SO, Lee EJC. Methicillin-resistant Staphylococcus aureus nasal carriage and infections in CAPD. Kidney Int 1993;41:1357-62.
47. Luzar MA, Brown CB, Balf D, Hill L, Issad B, Monnier B et al. Exit site care and exit-site infection in continuous ambulatory peritoneal dialysis (CAPD): results of a randomized multicenter trial. Perit Dial Int 1990;10:25-9.
48. Zimmerman SW, Ahrens E, Johnson CA, Craig W, Leggett J, O'Brien M et al. Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections. Am J Kidney Dis 1991;18:225-31.
49. The Mupirocin Study Group. Nasal mupirocin prevents Staphylococcus aureus exit site infection during peritoneal dialysis. Am Soc Nephrol 1996;11:2403-8.
50. Perez-Fontan M, Garcia-Falcon T, Rosales M, Rodriguez-Carmona A, Adeva M, Rodriguez-Lozano I et al. Treatment of Staphylococcus aureus nasal carriers in continuous ambulatory peritoneal dialysis with mupirocin: long-term results. Am J Kidney Dis 1992;22:708-12.
51. Bernardini J, Piraino B, Holley J, Johnston JR, Lutes R. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. Am J Kidney Dis 1996;27:695-700.
52. Zeybel M, Ozder A, Sanlidag C, Yildiz S, Cavdar C, Ersoy R et al. The effects of weekly mupirocin application on infections in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 2003;19:198-201.
53. Lobbedez T, Gardam M, Dedier H, Burdzy D, Chu M, Izatt S et al. Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years. Nephrol Dial Transplant 2004;19:3140-3.
54. Wong SS, Chu K, Cheuk A, Tsang WK, Fung SKS, Chan HWH et al. Prophylaxis against Gram positive organisms causing exit site infection and peritonitis in continuous ambulatory peritoneal dialysis patients by applying mupirocin ointment at the catheter exit site. Perit Dial Int 2003;23 Suppl 2:S153-8.
55. Annigeri R, Conly J, Vas SI, Dedier H, Prakashan KP, Bargman JM et al. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exitsite infection. Perit Dial Int 2001;21:554-9.
56. Perez-Fontan M, Rosales M, Rodriguez-Carmona A, Falcon TG, Valdes F. Mupirocin resistance after longterm use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am J Kidney Dis 2002;39:337-4l.
57. Bernardini J, Bender F, Florio T, Sloand J, Palmmontalbano L, Fried L et al. Randomized double blinded trial of peritoneal dialysis exit site mupirocin 2% versus gentamicin sulfate 0.1% cream. J Am Soc Nephrol 2005;16:539-45.
58. Cancarini GC, Manili L, Brunori G, Camerini C, Zubani R, Colombrita D et al. Simultaneous catheter replacement-removal during infectious complications in peritoneal dialysis. Adv Perit Dial 1994; 10:210-3.
59. Lui SL, Li FK, Lo CY, Lo WK. Simultaneous removal and reinsertion of Tenckhoff catheters for the treatment of refractory exit site infection. Adv Perit Dial 2000;16:195-7.
60. Mitra A, Teitelbaum I. Is it safe to simultaneously remove and replace infected peritoneal dialysis catheters? Review of the literature and suggested guidelines. Adv Perit Dial 2003;19:255-9.
61. Posthuma N, Borgstein PJ, Eijsbouts Q, Wee PM. Simultaneous peritoneal dialysis catheter insertion and removal in catheter-related infections without interruption of peritoneal dialysis. Nephrol Dial Transplant 1998;13:700-3.
62. Swartz R, Messana J, Reynolds J, Ranjit U. Simultaneous catheter replacement and removal in refractory peritoneal dialysis infections. Kidney Int 1991;40:1160-5.
63. Dasgupta MK, Ward K, Noble PA, Larabie M, Costerton JW. Development of bacterial biofilms on silastic catheter materials in peritoneal dialysis fluid. Am J Kidney Dis 1994;23:709-16.
64. Read RR, Eberwein P, Dasgupta MK, Grant SK, Lam K, Nickel JC et al. Peritonitis in peritoneal dialysis: bacterial colonization by biofilm spread along the catheter surface. Kidney Int 1989;35:614-21.
65. Mulhern JG, Braden GL, O'Shea, Madden RL, Lipkowitz GS, Germain MJ. Trough serum vancomycin levels predict the relapse of Gram-positive peritonitis in peritoneal dialysis patients. Am J Kidney Dis 1995;25:611-5.
66. Sepandj F, Ceri H, Gibb A, Read R, Olson M. Minimum inhibitory concentration versus minimum biofilm eliminating concentration in evaluation of antibiotic sensitivity of Gram negative bacilli causing peritonitis. Perit Dial Int 2004;24:65-7.
67. Finkelstein E, Jekel J, Troidle L, Gorban-Brennan N, Finkelstein FO, Bia FJ. Patterns of infection in patients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis. Am J Kidney Dis 2002;39:1278-86.
68. Goldie SJ, Liernan-Troidle L, Torres C, Gorban-Brennan N, Dunne D, Kliger AS et al. Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes. Am J Kidney Dis 1996;28:86-91.
69. Wang AY, Yu A, Li PK, Lam PK, Leung CB, Lai KN et al. Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center. Am J Kidney Dis 2000;36:1183-92.
70. Thodis E, Vas SI, Bargman JM, Singhal M, Chu M, Oreopoulos DG. Nystatin prophylaxis: its inability to prevent fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 1998;18:583-9.
71. Williams PF, Moncrieff N, Marriott J. No benefit in using nystatin prophylaxis against fungal peritonitis in peritoneal dialysis patients. Perit Dial Int 2000;20:352.
72. Lo WK, Chan CY, Cheng S, Poon JF, Chan DT, Cheng IK. A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1996;28:549-52.
73. Robitaille P, Merouani A, Clermont M, Hebert E. Successful antifungal prophylaxis in chronic peritoneal dialysis: a pediatric experience. Perit Dial Int 1995;15:77-9.
74. Wadhwa NK, Suh H, Cabralda T. Antifungal prophylaxis for secondary fungal peritonitis in peritoneal dialysis patients. Adv Perit Dial 1996;12:189-91.
75. Zaruba K, Peters J, Jungbluth H. Successful prophylaxis for fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: six years' experience. Am J Kidney Dis 1991;17:43-6.
76. Harwell CM, Newman LN, Cacho CP, Mulligan DC, Schulak JA, Friedlander MA. Abdominal catastrophe: visceral injury as a cause of peritonitis in patients treated by peritoneal dialysis. Perit Dial Int 1997;17:586-594.
77. Tzamaloukas AH, Obermiller LE, Gibel LJ, Murata GH, Wood B, Simon D et al. Peritonitis associated with intra-abdominal pathology in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 199313 Suppl 2:5335-7.
78. Wakeen MJ, Zimmerman SW, Bidwell D. Viscus perforation in peritoneal dialysis patients: diagnosis and outcome. Perit Dial Int 1994;14:371-7.
79. Wood CJ, Fleming V, Turnidge J, Thomson N, Atkins RC. Campylobacter peritonitis in continuous ambulatory peritoneal dialysis: report of eight cases and a review of the literature. Am J Kidney Dis 1992;29:257-63.
80. Singharetnam W, Holley JL. Acute treatment of constipation may lead to transmural migration of bacteria resulting in Gram negative, polymicrobial, or fungal peritonitis. Perit Dial Int 1996;16:423-5.
81. Holley JL, Bernardini J, Piraino B. Polymicrobial peritonitis in patients on continuous peritoneal dialysis. Am J Kidney D 1992;19:162-6.
82. Kim GC, Korbet SM. Polymicrobial peritonitis in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 2000;36:1000-8.
83. Fried L, Bernardini J, Piraino B. Iatrogenic peritonitis: the need for prophylaxis. Perit Dial Int 2000;20:343-5.
84. Troidle L, Kliger AS, Goldie SJ, Gorban-Brennan N, Brown E, Fikrig M et al. Continuous peritoneal dialysis-associated peritonitis of nosocomial origin. Perit Dial Int 1996;16:505-10.
85. Diaz-Buxo JA, Wick GS, Pesich A. Using CQI techniques for managing infections in PD patients. Nephrol News Issues 1998;12:22-4.